Maypharm
Metoo Fill+
Brand
Maypharm
Category
HA Filler
Origin
Korea
Options
Volume · Deep · Light
Available options
Interested in ordering Metoo Fill+? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Metoo Fill+ is Maypharm's second-generation cross-linked hyaluronic acid dermal filler line, built on a 3D HA cross-linking technology for durable results. The base range is offered in three grades (Volume, Deep, Light) matched to particle size, covering fine lines, deep folds and facial volumizing; a separate 'Point' tier adds lidocaine.
How it works
The cross-linked HA gel adds volume and binds water to hydrate and lift tissue. Depth and indication follow particle size and G-prime: Volume for deep volumizing, Deep for moderate-to-deep folds, and Light for shallow lines and delicate areas.
Indications
- Fine forehead, nasal-bridge and periorbital lines (Light)
- Lips, nasolabial folds and forehead wrinkles (Deep)
- Deep wrinkles and large-volume correction (Volume)
- Marionette lines and mid-face volumizing
Key features
- Second-generation cross-linked HA platform
- 3D HA cross-linking technology
- Three grades (Volume / Deep / Light)
- Easy tissue penetration to minimise trauma
- CE-marked HA filler
Benefits
- Grade range covers superficial to deep indications
- Cross-linking aimed at extended durability
- Lidocaine-free base option suits clinics preferring their own anaesthesia
- HA basis allows hyaluronidase reversal
Composition
Cross-linked hyaluronic acid, non-animal origin, 3D cross-linking; base Metoo Fill+ variants are supplied without lidocaine (lidocaine available in the Point line).
Usage & handling
Use standard HA technique: refrigerated storage, room-temperature equilibration, aseptic injection and vessel avoidance. When lidocaine-free, consider topical or local anaesthesia; keep hyaluronidase on hand for correction or vascular compromise.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.